Geron Corporation
Clinical trials sponsored by Geron Corporation, explained in plain language.
-
New drug aims to free patients from constant blood transfusions
Disease control OngoingThis study tested a drug called imetelstat for people with a bone marrow disorder called myelodysplastic syndrome (MDS). Participants had a low-risk form of MDS but still needed frequent blood transfusions because standard treatments had stopped working. The main goal was to see …
Phase: PHASE2, PHASE3 • Sponsor: Geron Corporation • Aim: Disease control
Last updated Apr 04, 2026 07:51 UTC
-
New hope for tough blood cancer: survival trial targets aggressive myelofibrosis
Disease control OngoingThis study is testing whether a new drug called imetelstat helps people with advanced myelofibrosis live longer compared to currently available treatments. It's for patients whose disease has worsened or didn't respond to standard JAK inhibitor medications. About 327 participants…
Phase: PHASE3 • Sponsor: Geron Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC